OVERVIEW

The market for ELISpot and FluoroSpot is projected to hit USD 453 million by 2026, rising at a CAGR of 14.3% over the forecast period, owing to the COVID-19 pandemic. The rising global incidence of chronic diseases, increased vaccine production to tackle antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers are all driving this market forward. In addition, t he effect of the COVID-19 outbreak on the industry will be thoroughly evaluated in the following report. The study also contrasts the pre-COVID-19 and post-COVID-19 markets.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global ELISpot and FluoroSpot Assay Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global ELISpot and FluoroSpot Assay Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global ELISpot and FluoroSpot Assay Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global ELISpot and FluoroSpot Assay Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global ELISpot and FluoroSpot Assay Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global ELISpot and FluoroSpot Assay Market ? By Product (Market Size ? & million/billion)
  • 8.1 Assay Kits
  • 8.2 Analyzers
  • 8.3 Ancillary Products

• 9 Global ELISpot and FluoroSpot Assay Market - By Application
  • 9.1 Diagnostic Applications
  • 9.2 Research Applications

• 10 Global ELISpot and FluoroSpot Assay Market - By End-User
  • 10.1 Hospitals & Clinical Laboratories
  • 10.2 Research Institutes
  • 10.3 Biopharmaceutical Companies

• 11 Global ELISpot and FluoroSpot Assay Market ? By Geography (Market Size ? &

• • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global ELISpot and FluoroSpot Assay Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global ELISpot and FluoroSpot Assay Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Oxford Immunotec
  • 13.3 Cellular Technology Limited (CTL)
  • 13.4 Mabtech AB
  • 13.5 Becton, Dickinson and Company
  • 13.6 Abcam
  • 13.7 U-Cytech Biosciences
  • 13.8 Bio-Techne
  • 13.9 Biotech Investissement Group
  • 13.10 Autoimmun Diagnostika GmbH
  • 13.11 Lophius Biosciences GmbH
  • 13.12 Company 11 & more

• 14 Global ELISpot and FluoroSpot Assay Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations